Lincoln Pharma reports Best-Ever Results in a Financial Year; Reports Highest Revenue, EBIDTA, Net Profit in FY22
Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd Company recommends 15% dividend, Rs. 1.50 per share for FY 22 Ahmedabad, May 20, 2022: FY22 Results Highlights:– (Standalone) · Net Profit Reports Y-o-Y growth of 11.42% to Rs. 69.36 crore; · Net Revenues from operations reports Y-o-Y growth of 11.63% to Rs. 472.08 crore; · […]
Continue Reading